Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caterina Cinti

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2004
A morphologic approach to detect apoptosis based on electron microscopyMartyn K White, Caterina Cinti
Frontiers in Immunology|August 22, 2017
Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor MicroenvironmentAnkush Sharma, Caterina Cinti, Enrico Capobianco
Oncogene|July 27, 2005
Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancerCaterina Cinti, Marcella Macaluso, Antonio Giordano
American Journal of Medical Genetics|January 25, 2002
Combined use of PRINS and FISH in the study of the dystrophin geneCaterina Cinti, Liborio Stuppia, Nadir Mario Maraldi
Cancer Informatics|May 6, 2016
Immunomediated Pan-cancer Regulation Networks are Dominant Fingerprints After Treatment of Cell Lines with DemethylationMariama El Baroudi, Caterina Cinti, Enrico Capobianco
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2006
Combined fluorescence in situ hybridization and PRINS for the analysis of the Dystrophin geneLiborio Stuppia, Dario La Sala, Caterina Cinti
Journal of Cellular Physiology|October 27, 2005
Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospectiveAnnalisa Roberti, Dario La Sala, Caterina Cinti
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2004
Multifluorescence labeling and colocalization analysesMassimo Riccio, Maja Dembic, Caterina Cinti, et al.
Current Pharmaceutical Biotechnology|May 28, 2016
Targeting Cancer with Epi-Drugs: A Precision Medicine PerspectiveLisa Gherardini, Ankush Sharma, Enrico Capobianco, et al.
Frontiers in Bioscience (Landmark Edition)|April 30, 2025
Epigenetic Reprogramming by Decitabine in RetinoblastomaLisa Gherardini, Ankush Sharma, Monia Taranta, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2004
A morphologic approach to detect apoptosis based on electron microscopyMartyn K White, Caterina Cinti
Frontiers in Immunology|August 22, 2017
Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor MicroenvironmentAnkush Sharma, Caterina Cinti, Enrico Capobianco
Oncogene|July 27, 2005
Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancerCaterina Cinti, Marcella Macaluso, Antonio Giordano
American Journal of Medical Genetics|January 25, 2002
Combined use of PRINS and FISH in the study of the dystrophin geneCaterina Cinti, Liborio Stuppia, Nadir Mario Maraldi
Cancer Informatics|May 6, 2016
Immunomediated Pan-cancer Regulation Networks are Dominant Fingerprints After Treatment of Cell Lines with DemethylationMariama El Baroudi, Caterina Cinti, Enrico Capobianco
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2006
Combined fluorescence in situ hybridization and PRINS for the analysis of the Dystrophin geneLiborio Stuppia, Dario La Sala, Caterina Cinti
Journal of Cellular Physiology|October 27, 2005
Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospectiveAnnalisa Roberti, Dario La Sala, Caterina Cinti
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2004
Multifluorescence labeling and colocalization analysesMassimo Riccio, Maja Dembic, Caterina Cinti, et al.
Current Pharmaceutical Biotechnology|May 28, 2016
Targeting Cancer with Epi-Drugs: A Precision Medicine PerspectiveLisa Gherardini, Ankush Sharma, Enrico Capobianco, et al.
Frontiers in Bioscience (Landmark Edition)|April 30, 2025
Epigenetic Reprogramming by Decitabine in RetinoblastomaLisa Gherardini, Ankush Sharma, Monia Taranta, et al.
Pageof 4